Key Insights

Highlights

Success Rate

97% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.3%

1 terminated out of 78 trials

Success Rate

96.6%

+10.0% vs benchmark

Late-Stage Pipeline

24%

19 trials in Phase 3/4

Results Transparency

18%

5 of 28 completed with results

Key Signals

5 with results97% success

Data Visualizations

Phase Distribution

65Total
Not Applicable (20)
Early P 1 (1)
P 1 (12)
P 2 (13)
P 3 (11)
P 4 (8)

Trial Status

Completed28
Unknown27
Recruiting13
Not Yet Recruiting6
Active Not Recruiting3
Terminated1

Trial Success Rate

96.6%

Benchmark: 86.5%

Based on 28 completed trials

Clinical Trials (78)

Showing 20 of 20 trials
NCT07557966Not ApplicableCompleted

Intrastromal Injection of Fluconazole in Treatment of Fungal Keratitis

NCT07000669Completed

Bilateral Peribulbar Block for Cataract Surgery

NCT05776550Active Not Recruiting

Safety and Efficacy of Distal Radial Access (SAFE-BOX)

NCT03943875Phase 4Completed

GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

NCT04592640Early Phase 1Recruiting

Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis

NCT06243354Phase 1Recruiting

Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation

NCT06639256Phase 1Recruiting

Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors

NCT07323251Not ApplicableRecruiting

Clinical Study on the Effectiveness of Diverse Segments Defocus Optimization in Spectacle Lenses for Slowing Myopia Progression

NCT06120712Phase 1Completed

A Study of GC101 TIL in Advanced Melanoma (BZ)

NCT05417750Phase 1Completed

A Phase I Study of GC101 TIL in Advanced Solid Tumors

NCT06976229Phase 1Recruiting

Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial

NCT06974968Phase 2Not Yet Recruiting

Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial

NCT06281886Phase 2Active Not Recruiting

Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma

NCT07130617Phase 1Not Yet RecruitingPrimary

Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

NCT07021521Not ApplicableCompleted

Midazolam Efficacy/Safety in Pre-Eclamptic C-Section Sedation

NCT03790631Completed

The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring

NCT05556291CompletedPrimary

Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study

NCT06642428Not ApplicableRecruiting

Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer

NCT06123832UnknownPrimary

Study of the Clinical Benefits of Different Formulations of Amphotericin B

NCT06196814Phase 1Not Yet RecruitingPrimary

AK112 Plus Platinum-based Chemotherapy for EGFR/ALK/ROS1 Positve NSCLC

Scroll to load more

Research Network

Activity Timeline